Updated efficacy and safety of larotrectinib (laro) in patients (pts) with TRK fusion gastrointestinal (GI) cancer Meeting Abstract
| Authors: | Shen, L.; Andre, T.; Chung, H. C. C.; Deeken, J. F.; Garralda, E.; Italiano, A.; Leyvraz, S.; Liu, T.; Burcoveanu, D. I.; Grugel, R.; Mussi, C. E.; Xu, R. H.; Hong, D. S.; Drilon, A. E.; Berlin, J. |
| Abstract Title: | Updated efficacy and safety of larotrectinib (laro) in patients (pts) with TRK fusion gastrointestinal (GI) cancer |
| Meeting Title: | 2024 ASCO Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2024 Jan 18-20 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-01-20 |
| Language: | English |
| ACCESSION: | WOS:001266680500708 |
| DOI: | 10.1200/JCO.2024.42.3_suppl.109 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 109 -- Source: Wos |
